The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its insulin ... (3 vials or 2 packs of pens) for customers paying with cash.
Hosted on MSN1mon
Novo Nordisk settles Minnesota insulin pricing case: reportNovo Nordisk (NVO) is the latest drugmaker to reach an agreement with the state of Minnesota over insulin prices. Eli Lilly (LLY) and Sanofi (SNY) settled similar cases with the state last year.
Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Long-Term Pick’s Substack by Dan. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)’s share ...
Novo Nordisk only ... which is tied to Insulin, through the threat of biosimilars. Therefore, as long as the growth story for GLP-1 is sound, there is a strong case for an investment in the ...
Novo Nordisk ... case is that it will continue," Jørgensen said on a call with reporters early Wednesday. The company is no stranger to the process, having just had prices set for some of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results